Year ended | Year ended | ||
31 March 2024 | 31 March 2023 | ||
Notes | £m | £m | |
Fee and other operating income | 3 | ||
Finance loss | 5 | ( | ( |
Net gains on investments | 9 | ||
Total Revenue | |||
Other income | 8 | ||
Finance costs | 10 | ( | ( |
Administrative expenses | 11 | ( | ( |
Share of results of joint ventures accounted for using the equity method | 29 | ( | |
Profit before tax from continuing operations | |||
Tax charge | 13 | ( | ( |
Profit after tax from continuing operations | |||
Profit/(loss)aftertaxondiscontinuedoperations | 28 | ||
Profit for the year | |||
Attributable to: | |||
Equity holders of the parent | |||
Non-controlling interests | ( | ||
Earnings per share attributable to ordinary equity | |||
holders of the parent | |||
Basic (pence) | 15 | ||
Diluted (pence) | 15 | ||
Earnings per share for profit from continuing operations | |||
attributable to ordinary equity holders of the parent | |||
Basic (pence) | 15 | ||
Diluted (pence) | 15 |
Year ended | Year ended | ||
31 March 2024 | 31 March 2023 | ||
Group | Notes | £m | £m |
Profitaftertax | |||
Items that may be subsequently reclassified to profit or loss if specific conditions are met | |||
Exchange differences on translation of foreign operations | ( | ||
Deferred tax on equity investments translation | ( | ||
Total comprehensive income for the year | |||
Attributable to: | |||
Equity holders of the parent | |||
Non-controlling interests | ( | ||
31 March 2024 | 31 March 2023 | ||
Group | Group | ||
Notes | £m | £m | |
Non-current assets | |||
Intangible assets | 16 | ||
Property, plant and equipment | 17 | ||
Investment property | 18 | ||
Investment in Joint Venture accounted for under the equity method | 29 | ||
Trade and other receivables | 19 | ||
Financial assets at fair value | 5 | ||
Derivativefinancialassets | 5 | ||
Deferred tax asset | 13 | ||
Current assets | |||
Trade and other receivables | 19 | ||
Current tax debtor | |||
Financial assets at fair value | 5 | ||
Derivativefinancialassets | 5 | ||
Cash and cash equivalents | 6 | ||
Assets of disposal groups held for sale | 28 | ||
Total assets |
31 March 2024 | 31 March 2023 | ||
Group | Group | ||
Notes | £m | £m | |
Non-current liabilities | |||
Trade and other payables | 20 | ||
Financial liabilities at fair value | 5, 7 | ||
Financial liabilities at amortised cost | 7 | ||
Otherfinancialliabilities | 7 | ||
Derivativefinancialliabilities | 5, 7 | ||
Deferred tax liabilities | 13 | ||
Current liabilities | |||
Trade and other payables | 20 | ||
Current tax creditor | |||
Financial liabilities at amortised cost | 7 | ||
Otherfinancialliabilities | 7 | ||
Derivativefinancialliabilities | 5, 7 | ||
Liabilitiesofdisposalgroupsheldforsale | 28 | ||
Total liabilities | |||
Equity and reserves | |||
Called up share capital | 22 | ||
Share premium account | 22 | ||
Other reserves | |||
Retained earnings | |||
Equity attributable to owners of the Company | |||
Non-controlling interest | ( | ||
Total equity | |||
Total equity and liabilities |
Year ended | Year ended | ||
31 March 2024 | 31 March 2023 | ||
Group | Group | ||
Notes | £m | £m | |
Cash flows generated from operations | |||
Taxes paid | ( | ( | |
Net cash flows from operating activities | 31 | ||
Investing activities | |||
Purchase of intangible assets | 16 | ( | ( |
Purchase of property, plant and equipment | 17 | ( | ( |
Netcashflowfromderivativefinancialinstruments | ( | ||
Cashflowasaresultofchangeincontrolofsubsidiary | |||
Net cash flows from investing activities | |||
Financing activities | |||
Purchase of own shares | 23 | ( | |
Payment of principal portion of lease liabilities | 7 | ( | ( |
Repayment of long-term borrowings | ( | ( | |
Dividends paid to equity holders of the parent | 14 | ( | ( |
Net cash flows used in financing activities | ( | ( | |
Net increase/(decrease) in cash and cash equivalents | ( | ||
Effects of exchange rate differences on cash and cash equivalents | ( | ||
Cash and cash equivalents at 1 April | 6 | ||
Cash and cash equivalents at 31 March | 6 |
Other reserves | ||||||||||
Share-based | Foreign | |||||||||
Share | Share | Capital | payments | Own | currency | Non- | ||||
capital | premium | redemption | reserve | shares | translation | Retained | controlling | Total | ||
(note 22) | (note 22) | reserve | (note 24) | (note 23) | reserve2 | earnings | Total | interest | equity | |
Group | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
Balance at 1 April 2023 | ( | |||||||||
Profitaftertax | ||||||||||
Exchange differences on translation of foreign operations | ( | ( | ( | |||||||
Deferred tax on equity investments translation | ( | ( | ( | |||||||
Total comprehensive income/(expense) for the year | ( | |||||||||
Adjustment of non-controlling interest on disposal of subsidiary | ( | ( | ||||||||
Issue of share capital | ||||||||||
Options/awards exercised | ( | ( | ( | ( | ||||||
Tax on options/awards exercised | ||||||||||
Credit for equity settled share schemes | ||||||||||
Dividends paid (note 14) | ( | ( | ( | |||||||
Balance at 31 March 2024 | ( | ( |
Other reserves | ||||||||||
Share-based | Foreign | |||||||||
Share | Share | Capital | payments | Own | currency | Non- | ||||
capital | premium | redemption | reserve | shares | translation | Retained | controlling | Total | ||
(note 22) | (note 22) | reserve | (note 24) | (note 23) | reserve | earnings | Total | interest | equity | |
Group | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
Balance at 1 April 2022 | ( | |||||||||
Profitaftertax | ( | |||||||||
Exchange differences on translation of foreign operations | ||||||||||
Deferred tax on equity investments translation | ||||||||||
Total comprehensive income/(expense) for the year | ( | |||||||||
Adjustment of non-controlling interest on disposal of subsidiary | ( | ( | ( | ( | ||||||
Acquisition of non-controlling interest | ||||||||||
Issue of share capital | ||||||||||
Own shares acquired in the year | ( | ( | ( | |||||||
Options/awards exercised | ( | ( | ( | ( | ||||||
Tax on options/awards exercised | ( | ( | ( | |||||||
Credit for equity settled share schemes | ||||||||||
Dividends paid (note 14) | ( | ( | ( | |||||||
Balance at 31 March 2023 | - |
1 January 2024 |
Year ended | Year ended | |
31 March 2024 | 31 March 2023 | |
Type of contract/service | £m | £m |
Management fees | 552.7 | 481.6 |
Other income | 2.1 | 2.0 |
Fee and other operating income | 554.8 | 483.6 |
Year ended 31 March 2024 | Year ended 31 March 2023 | |||||
Reportable | Reportable | |||||
FMC | IC | segments Total | FMC | IC | segments Total | |
£m | £m | £m | £m | £m | £m | |
External fee income | 579.1 | – | 579.1 | 501.0 | 2.6 | 503.6 |
Inter-segmental fee | 25.0 | (25.0) | – | 25.0 | (25.0) | – |
Other operating income | 0.9 | 1.0 | 1.9 | 0.5 | 1.7 | 2.2 |
Fund management fee income | 605.0 | (24.0) | 581.0 | 526.5 | (20.7) | 505.8 |
Net investment returns | – | 379.3 | 379.3 | – | 102.3 | 102.3 |
Dividend income | 47.0 | – | 47.0 | 40.2 | – | 40.2 |
Net fair value (loss)/gain on derivatives | – | (7.3) | (7.3) | (26.8) | 16.8 | (10.0) |
Total revenue | 652.0 | 348.0 | 1,000.0 | 539.9 | 98.4 | 638.3 |
Interest income | – | 21.5 | 21.5 | – | 13.9 | 13.9 |
Interest expense | (2.2) | (45.8) | (48.0) | (2.2) | (61.8) | (64.0) |
Staff costs | (101.0) | (21.4) | (122.4) | (85.0) | (20.0) | (105.0) |
Incentive scheme costs | (113.3) | (58.6) | (171.9) | (92.2) | (59.6) | (151.8) |
Other administrative expenses | (61.0) | (20.4) | (81.4) | (49.8) | (23.5) | (73.3) |
Profit before tax and discontinued operations | 374.5 | 223.3 | 597.8 | 310.7 | (52.6) | 258.1 |
Year ended 31 March 2024 | Year ended 31 March 2023 | |||||
Reportable | Consolidated | Financial | Reportable | Consolidated | Financial | |
segments | entities | statements | segments | entities | statements | |
£m | £m | £m | £m | £m | £m | |
Fund management fee income | 579.1 | (26.4) | 552.7 | 503.6 | (22.0) | 481.6 |
Other operating income | 1.9 | 0.2 | 2.1 | 2.2 | (0.2) | 2.0 |
Fee and other income | 581.0 | (26.2) | 554.8 | 505.8 | (22.2) | 483.6 |
Dividend income | 47.0 | (47.0) | – | 40.2 | (40.2) | – |
Net fair value loss on derivatives | (7.3) | (3.2) | (10.5) | (10.0) | (7.1) | (17.1) |
Finance income/(loss) | 39.7 | (50.2) | (10.5) | 30.2 | (47.3) | (17.1) |
Net investment returns/gains on investments | 379.3 | 26.0 | 405.3 | 102.3 | 70.2 | 172.5 |
Total revenue | 1,000.0 | (50.4) | 949.6 | 638.3 | 0.7 | 639.0 |
Other income | 21.5 | 0.1 | 21.6 | 13.9 | 1.6 | 15.5 |
Finance costs | (48.0) | (1.5) | (49.5) | (64.0) | (0.6) | (64.6) |
Staff costs | (122.4) | – | (122.4) | (105.0) | (0.1) | (105.1) |
Incentive scheme costs | (171.9) | – | (171.9) | (151.8) | 0.2 | (151.6) |
Other administrative expenses | (81.4) | (14.8) | (96.2) | (73.3) | (13.3) | (86.6) |
Administrative expenses | (375.7) | (14.8) | (390.5) | (330.1) | (13.2) | (343.3) |
Share of results of joint ventures accounted for using equity method | – | (0.4) | (0.4) | – | 4.4 | 4.4 |
Profit before tax and discontinued operations | 597.8 | (67.0) | 530.8 | 258.1 | (7.1) | 251.0 |
Tax charge | (78.5) | 16.1 | (62.4) | (28.8) | (0.6) | (29.4) |
Profit after tax from discontinued operations | – | 6.0 | 6.0 | – | 56.8 | 56.8 |
Profit after tax and discontinued operations | 519.3 | (44.9) | 474.4 | 229.3 | 49.1 | 278.4 |
2024 | 2023 | |||||
Reportable | Consolidated | Financial | Reportable | Consolidated | Financial | |
segments | entities | statements | segments | entities | statements | |
Year ended 31 March 2024 | £m | £m | £m | £m | £m | £m |
Non-current financial assets | 2,713.7 | 4,682.7 | 7,396.4 | 2,642.2 | 4,402.8 | 7,045.0 |
Other non-current assets | 166.5 | 82.9 | 249.4 | 158.4 | 6.0 | 164.4 |
Cash | 627.4 | 362.6 | 990.0 | 550.0 | 407.5 | 957.5 |
Current financial assets | 366.6 | (289.0) | 77.6 | 282.4 | (264.1) | 18.3 |
Other current assets | 299.1 | 109.6 | 408.7 | 243.7 | 623.6 | 867.3 |
Total assets | 4,173.3 | 4,948.8 | 9,122.1 | 3,876.7 | 5,175.8 | 9,052.5 |
Non-current financial liabilities | 1,266.4 | 4,632.1 | 5,898.5 | 1,558.0 | 4,573.4 | 6,131.4 |
Other non-current liabilities | 87. 3 | 1.1 | 88.4 | 104.5 | 2.1 | 106.6 |
Current financial liabilities | 268.4 | 0.1 | 268.5 | 79.1 | – | 79.1 |
Other current liabilities | 255.8 | 311.2 | 567.0 | 157.7 | 532.5 | 690.2 |
Total liabilities | 1,877.9 | 4,944.5 | 6,822.4 | 1,899.3 | 5,108.0 | 7,007.3 |
Equity | 2,295.4 | 4.3 | 2,299.7 | 1,977.4 | 67.8 | 2,045.2 |
Total equity and liabilities | 4,173.3 | 4,948.8 | 9,122.1 | 3,876.7 | 5,175.8 | 9,052.5 |
2024 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Profit/(loss) before tax from continuing operations | 597.8 | (67.0) | 530.8 |
Adjustments for non-cash items: | |||
Fee and other operating (income)/expense | (581.0) | 26.2 | (554.8) |
Net investment returns | (379.3) | (26.0) | (405.3) |
Net fair value (gain)/loss on derivatives | (23.5) | 0.7 | (22.8) |
Impact of movement in foreign exchange rates | 30.9 | 2.4 | 33.3 |
Interest income | (68.5) | 46.9 | (21.6) |
Interest expense | 48.0 | 1.5 | 49.5 |
Depreciation, amortisation and impairment of property, plant, equipment and intangible assets | 18.0 | – | 18.0 |
Share-based payment expense | 43.9 | – | 43.9 |
Working capital changes: | |||
Increase in trade receivables | (8.5) | (80.2) | (88.7) |
Increase/(decrease) in trade and other payables | 50.5 | (68.2) | (17.7) |
(271.7) | (163.7) | (435.4) | |
Proceeds from sale of current financial assets and disposal groups held for sale | 319.2 | – | 319.2 |
Purchase of current financial assets and disposal groups | |||
held for sale | (312.1) | – | (312.1) |
Purchase of investments | (322.5) | (1,407.2) | (1,729.7) |
Proceeds from sales and maturities of investments | 403.0 | 1,830.1 | 2,233.1 |
Redemption of CLO notes1 | – | (389.1) | (389.1) |
Interest and dividend income received | 122.2 | 372.0 | 494.2 |
Fee and other operating income received | 492.0 | 4.4 | 496.4 |
Interest paid | (49.3) | (330.2) | (379.5) |
Cash flow generated from/(used in) operations | 380.8 | (83.7) | 297.1 |
Taxes paid | (41.2) | – | (41.2) |
Net cash flows from/(used in) operating activities | 339.6 | (83.7) | 255.9 |
2024 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Investing activities | |||
Purchase of intangible assets | (6.3) | – | (6.3) |
Purchase of property, plant and equipment | (3.2) | – | (3.2) |
Net cash flow from derivative financial instruments | 31.5 | – | 31.5 |
Cash flow as a result of acquisition of subsidiaries | – | 49.5 | 49.5 |
Net cash flows from investing activities | 22.0 | 49.5 | 71.5 |
Financing activities | |||
Payment of principal portion of lease liabilities | (8.4) | – | (8.4) |
Repayment of long-term borrowings | (50.7) | – | (50.7) |
Dividends paid to equity holders of the parent | (223.4) | – | (223.4) |
Net cash flows used in financing activities | (282.5) | – | (282.5) |
Net increase/decrease in cash and cash equivalents | 79.1 | (34.2) | 44.9 |
Effects of exchange rate differences on cash and cash | |||
equivalents | (1.7) | (10.7) | (12.4) |
Cash and cash equivalents at 1 April | 550.0 | 407.5 | 957.5 |
Cash and cash equivalents at 31 March | 627.4 | 362.6 | 990.0 |
2023 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Profit/(loss) before tax from continuing operations | 258.1 | (7.1) | 251 |
Adjustments for non-cash items: | |||
Fee and other operating (income)/expense | (505.8) | 22.2 | (483.6) |
Net investment returns | (102.3) | (70.2) | (172.5) |
Net fair value loss on derivatives | 34.9 | – | 34.9 |
Impact of movement in foreign exchange rates | (24.9) | 7.1 | (17.8) |
Interest income | (13.9) | (1.6) | (15.5) |
Interest expense | 64.0 | 0.6 | 64.6 |
Depreciation, amortisation and impairment of property, plant, equipment and intangible assets | 18.2 | – | 18.2 |
Share-based payment expense | 39.5 | 0 | 39. 5 |
Change in disposal groups held for sale | – | (8.8) | (8.8) |
Working capital changes: | |||
(Increase)/decrease in trade receivables | (48.3) | 36.3 | (12.0) |
Decrease in trade and other payables | (41.3) | (155.6) | (196.9) |
(321.8) | (177.1) | (498.9) | |
Proceeds from sale of current financial assets and disposal groups held for sale | 45.5 | – | 45.5 |
Purchase of current financial assets and disposal groups | |||
held for sale | (211.9) | – | (211.9) |
Purchase of investments | (453.8) | (920.8) | (1,374.6) |
Proceeds from sales and maturities of investments | 689.4 | 1,032.4 | 1,721.8 |
Issuance of CLO notes1 | – | 0.4 | 0.4 |
Redemption of CLO notes1 | – | (45.6) | (45.6) |
Interest and dividend income received | 106.8 | 256.0 | 362.8 |
Fee and other operating income received | 573.3 | 14.6 | 587.9 |
Interest paid | (63.5) | (199.9) | (263.4) |
Cash flow generated from/(used in) operations | 363.9 | (39.9) | 324.0 |
Taxes paid | (32.4) | – | (32.4) |
Net cash flows from/(used in) operating activities | 331.5 | (39.9) | 291.6 |
2023 | |||
Reportable | Consolidated | Financial | |
segments | entities | Statements | |
£m | £m | £m | |
Investing activities | |||
Purchase of intangible assets | (4.7) | – | (4.7) |
Purchase of property, plant and equipment | (6.5) | – | (6.5) |
Net cash flow from derivative financial instruments | (58.8) | – | (58.8) |
Cash flow as a result of acquisition of subsidiaries | – | 200.8 | 200.8 |
Net cash flows (used in)/from investing activities | (70.0) | 200.8 | 130.8 |
Financing activities | |||
Purchase of Own Shares | (38.9) | – | (38.9) |
Payment of principal portion of lease liabilities | (6.8) | – | (6.8) |
Repayment of long-term borrowings | (194.6) | – | (194.6) |
Dividends paid to equity holders of the parent | (236.4) | – | (236.4) |
Net cash flows used in financing activities | (476.7) | – | (476.7) |
Net (decrease)/increase in cash and cash equivalents | (215.2) | 160.9 | (54.3) |
Effects of exchange rate differences on cash and cash | |||
equivalents | 3.7 | 16.3 | 20.0 |
Cash and cash equivalents at 1 April | 761.5 | 230.3 | 991.8 |
Cash and cash equivalents at 31 March | 550.0 | 407.5 | 957.5 |
Year ended | Year ended | |
31 March 2024 | 31 March 2023 | |
£m | £m | |
Europe (including UK) | 132.5 | 116.4 |
Asia Pacific | 62.5 | 7.3 |
North America | 54.4 | 40.7 |
Total | 249.4 | 164.4 |
Year ended | Year ended | |
31 March 2024 | 31 March 2023 | |
Income Analysis by Geography | £m | £m |
Europe (including UK) | 726.5 | 415.3 |
Asia Pacific | 87.2 | 58.6 |
North America | 135.9 | 165.1 |
Total | 949.6 | 639.0 |
As at 31 March 2024 | As at 31 March 2023 | |||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
Group | £m | £m | £m | £m | £m | £m | £m | £m |
Financial assets | ||||||||
Investment in or alongside managed funds | 5.7 | 3.6 | 2,300.7 | 2,310.0 | 7.2 | 1.8 | 2,144.3 | 2,153.3 |
Consolidated CLOs and credit funds | – | 4,154.9 | 462.6 | 4,617.5 | – | 4,101.4 | 567.7 | 4,669.1 |
Derivative assets | – | 9.3 | – | 9.3 | – | 22.0 | – | 22.0 |
Investment in private companies | – | – | 401.7 | 401.7 | – | – | 100.4 | 100.4 |
Investment in public companies | 4.5 | – | – | 4.5 | 5.1 | – | – | 5.1 |
Non-consolidated CLOs and credit funds | – | 111.3 | 19.7 | 131.0 | – | 105.8 | 7. 5 | 113.3 |
Disposal groups held for sale | – | – | – | – | – | – | 163.2 | 163.2 |
Total financial assets | 10.2 | 4,279.1 | 3,184.7 | 7,474.0 | 12.3 | 4,231.0 | 2,983.1 | 7,226.4 |
Financial liabilities | ||||||||
Liabilities of consolidated CLOs and credit funds | – | (4,415.6) | (186.7) | (4,602.3) | – | (4,508.0) | (64.7) | (4,572.7) |
Derivative liabilities | – | (9.2) | – | (9.2) | – | (15.7) | – | (15.7) |
Disposal groups held for sale | – | – | – | – | – | – | – | – |
Total financial liabilities | – | (4,424.8) | (186.7) | (4,611.5) | – | (4,523.7) | (64.7) | (4,588.4) |
As at 31 March 2024 | As at 31 March 2023 | |||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
Company | £m | £m | £m | £m | £m | £m | £m | £m |
Financial Assets | ||||||||
Investment in or alongside managed funds | 5.8 | – | 128.3 | 134.1 | 7.2 | – | 171.6 | 178.8 |
Derivative assets | – | 9.3 | – | 9.3 | – | 22.0 | – | 22.0 |
Investment in private companies | – | – | 87.1 | 87.1 | – | – | 86.1 | 86.1 |
Senior and subordinated notes of CLO vehicles | – | – | 21.8 | 21.8 | – | – | 23.8 | 23.8 |
Total assets | 5.8 | 9.3 | 237.2 | 252.3 | 7.2 | 22.0 | 281.5 | 310.7 |
Financial Liabilities | ||||||||
Derivative liabilities | – | 9.2 | – | 9.2 | – | 15.7 | – | 15.7 |
Total liabilities | – | 9.2 | – | 9.2 | – | 15.7 | – | 15.7 |
Investment in | ||||||
Investment in or | loans held in | Investment in | Subordinated | |||
alongside | consolidated | private | notes of CLO | Disposal groups | ||
managed funds | entities | companies | vehicles | held for sale | Total | |
Group | £m | £m | £m | £m | £m | £m |
At 1 April 2023 | 2,144.3 | 567.7 | 100.4 | 7. 5 | 163.2 | 2,983.1 |
Total gains or losses in the income statement | ||||||
– Net investment return | 284.0 | 11.5 | 14.4 | 2.9 | 63.3 | 376.1 |
– Foreign exchange | (50.7) | (14.0) | (4.3) | (0.4) | 3.4 | (66.0) |
Purchases | 301.8 | 234.2 | 74.5 | 9.7 | 213.1 | 833.3 |
Exit proceeds | (378.7) | (195.6) | (19.1) | – | (207.2) | (800.6) |
Transfers in | – | 96.9 | – | – | – | 96.9 |
Transfers out | – | (238.1) | – | – | – | (238.1) |
Reclassification | – | – | 235.8 | – | (235.8) | – |
At 31 March 2024 | 2,300.7 | 462.6 | 401.7 | 19.7 | – | 3,184.7 |
Investment in | ||||||
Investment in or | loans held in | Investment in | Subordinated | |||
alongside | consolidated | private | notes of CLO | Disposal groups | ||
managed funds | entities | companies | vehicles | held for sale | Total | |
Group | £m | £m | £m | £m | £m | £m |
At 1 April 2022 | 2,112.9 | 145.2 | 122.7 | 9.1 | 89.2 | 2,479.1 |
Total gains or losses in the income statement | ||||||
– Net investment return | 172.9 | (9.6) | (21.2) | (1.3) | (7.1) | 133.7 |
– Foreign exchange | 67.4 | 15.5 | 13.2 | 0.5 | 5.8 | 102.4 |
Purchases | 416.2 | 60.2 | 6.7 | – | 158.7 | 641.8 |
Exit proceeds | (625.1) | (100.7) | (21.0) | (0.8) | (23.8) | (771.4) |
Transfers in | – | 457.1 | – | – | – | 457.1 |
Transfers out | – | – | – | – | (59.6) | (59.6) |
At 31 March 2023 | 2,144.3 | 567.7 | 100.4 | 7. 5 | 163.2 | 2,983.1 |
Company | ||||||||
2024 | 2023 | |
Financial | Financial | |
liabilities | liabilities | |
designated as | designated as | |
FVTPL | FVTPL | |
Group | £m | £m |
At 1 April | 64.7 | 239.6 |
Total gains or losses in the income statement | ||
– Fair value gains | 102.3 | (178.2) |
– Foreign exchange losses | (1.7) | 12.8 |
Purchases | 21.4 | 23.8 |
Disposal groups held for sale | – | (5.0) |
Transfer between levels | – | (28.3) |
At 31 March | 186.7 | 64.7 |
Fair Value | Fair Value | Effect on Fair | ||||||
As at | As at | Weighted | Value | |||||
31 March 2024 | 31 March 2023 | Key Unobservable | Average/ Fair | Sensitivity/ | 31 March 2024 | |||
Group assets | £m | £m | Primary Valuation Technique | Inputs | Range | Value Inputs | Scenarios | £m |
Structured & Private Equity: Corporate | 1,490.6 | 1,341.3 | Market comparable companies | Earnings multiple | 5.0x – 29.0x | 15.1x | '+10% Earnings multiple2 | 187.6 |
Investments & US Mid-Market | Discounted cash flow | Discount rate | 7.5% - 20.5% | 11.2% | '-10% Earnings multiple2 | (187.6) | ||
Earnings multiple | 6.1x – 21.5x | 11.8x | ||||||
Structured & Private Equity: Strategic Equity, LP | 589.9 | 589.4 | Third-party valuation / funding | N/A | N/A | N/A | +10% valuation | 59.0 |
Secondaries, Recovery Fund, Life Sciences | round value | |||||||
-10% valuation | (59.0) | |||||||
Private Debt: North American Credit Partners | 91.7 | 120.7 | Market comparable companies | Earnings multiple | 5.5x – 29.0x | 14.1x | '+10% Earnings multiple | 9.7 |
'-10% Earnings multiple | (9.7) | |||||||
Private Debt: Senior Debt Partners | 58.2 | 47.8 | Probability of default | 1.0%-2.2% | 1.0% | Upside case | – | |
Loss given default | 32.2% | 32.2% | Downside case | (0.5) | ||||
Discounted cash flow | Maturity of loan | 3 years | 3 years | |||||
Effective interest | 9.6%-11.5% | 11.2% | ||||||
rate | ||||||||
Real Assets | 441.4 | 293.6 | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | 44.1 |
LTV-based impairment model | N/A | N/A | N/A | -10% Third-party valuation | (44.1) | |||
Credit: Non-consolidated CLOs and credit funds | 19.7 | 7. 5 | Discount rate | 15.0% - 15.5% | 15.1% | |||
Default rate | 3% - 4.5% | 3.3% | Upside case | 22.8 | ||||
Discounted cash flow | Prepayment rate % | 15% -20% | 19.5% | Downside case | (23.8) | |||
Recovery rate % | 75.0% | 75.0% | ||||||
Reinvestment price | 99.5% | 99.5% | ||||||
Credit: Consolidated CLOs and credit funds | 462.6 | 567.7 | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | 46.3 |
-10% Third-party valuation | (46.3) | |||||||
Credit: Liquid Funds | 30.6 | 15.1 | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | 3.1 |
-10% Third-party valuation | (3.1) | |||||||
Total financial assets | 3,184.7 | 2,983.1 | Total Upside sensitivity | 372.5 | ||||
Total Downside sensitivity | (374.1) | |||||||
Liabilities of Consolidated CLOs and credit funds | (186.7) | (64.7) | Third-party valuation | N/A | N/A | N/A | +10% Third-party valuation | (18.7) |
-10% Third-party valuation | 18.7 | |||||||
Total financial liabilities | (186.7) | (64.7) |
2024 | 2023 | |||||
Contract or | Fair values | Contract or | Fair values | |||
underlying | underlying | |||||
principal amount | Asset | Liability | principal amount | Asset | Liability | |
Group | £m | £m | £m | £m | £m | £m |
Cross currency swaps | 118.8 | 6.2 | (5.5) | 121.6 | 7. 5 | (8.5) |
Forward foreign exchange contracts | 1,201.8 | 3.1 | (3.7) | 1,365.1 | 14.5 | (7.2) |
Total | 1,320.6 | 9.3 | (9.2) | 1,486.7 | 22.0 | (15.7) |
2024 | 2023 | |||||
Contract or | Fair values | Contract or | Fair values | |||
underlying | underlying | |||||
principal amount | Asset | Liability | principal amount | Asset | Liability | |
Company | £m | £m | £m | £m | £m | £m |
Cross currency swaps | 118.8 | 6.2 | (5.5) | 121.6 | 7. 5 | (8.5) |
Forward foreign exchange contracts | 1,201.8 | 3.1 | (3.7) | 1,365.1 | 14.5 | (7.2) |
Total | 1,320.6 | 9.3 | (9.2) | 1,486.7 | 22.0 | (15.7) |
Group | Company | |||
2024 | 2023 | 2024 | 2023 | |
£m | £m | £m | £m | |
Cash and cash equivalents | ||||
Cash at bank and in hand | 990.0 | 957.5 | 464.4 | 409.8 |
2024 | 2023 | |||||
Interest rate | Current | Non-current | Current | Non-current | ||
Group | % | Maturity | £m | £m | £m | £m |
Liabilities held at amortised cost | ||||||
– Private placement | 2.02% - 5.35% | 2024 - 2029 | 248.7 | 346.4 | 56.8 | 604.8 |
–Listed notes and bonds | 1.63% - 2.50% | 2027 - 2030 | 2.5 | 851.3 | 2.5 | 874.9 |
– Unsecured bank debt | SONIA +1.38% | 2026 | (0.8) | (0.7) | (0.8) | (1.5) |
Total Liabilities held at amortised cost | 250.4 | 1,197.0 | 58.5 | 1,478.2 | ||
Lease liabilities | 2.85% - 7.09% | 2024 - 2034 | 8.9 | 69. 3 | 5.8 | 79.6 |
Other financial liabilities | 1.34% - 6.20% | 2024 - 2028 | – | 29.9 | – | – |
Liabilities held at FVTPL: | ||||||
–Derivative financial liabilities | 9.2 | – | 14.8 | 0.9 | ||
– Structured entities controlled by the Group | 0.60% - 10.90% | 2030-2038 | – | 4,602.3 | – | 4,572.7 |
268.5 | 5,898.5 | 79.1 | 6,131.4 |
2024 | 2023 | |||||
Interest rate | Current | Non-current | Current | Non-current | ||
Company | % | Maturity | £m | £m | £m | £m |
Liabilities held at amortised cost | ||||||
– Private placement | 2.02% - 5.35% | 2024 - 2029 | 248.7 | 346.4 | 56.8 | 604.8 |
–Listed notes and bonds | 1.63% - 2.50% | 2027 - 2030 | 2.5 | 851.3 | 2.5 | 874.9 |
– Unsecured bank debt¹ | SONIA +1.38% | 2026 | (0.8) | (0.7) | (0.8) | (1.5) |
Total Liabilities held at amortised cost | 250.4 | 1,197.0 | 58.5 | 1,478.2 | ||
Lease liabilities | 2.85% - 7.09% | 2024 - 2034 | 4.4 | 34.9 | 4.3 | 39. 3 |
Liabilities held at FVTPL | ||||||
–Derivative financial liabilities | 9.2 | – | 14.8 | 0.9 | ||
264.0 | 1,231.9 | 77.6 | 1,518.4 |
Group | Company | |||
2024 | 2023 | 2024 | 2023 | |
£m | £m | £m | £m | |
At 1 April | 1,622.1 | 1,712.1 | 1,580.3 | 1,701.3 |
Movement as a result of change in control of subsidiary | 21.5 | – | – | – |
Repayment of long term borrowings | (50.7) | (194.6) | (50.7) | (194.6) |
Reclassification1 | 7.7 | – | – | – |
Payment of principal portion of lease liabilities | (8.4) | (6.8) | (5.8) | (4.1) |
Establishment of lease liability | 1.2 | 33.0 | – | – |
Net interest movement | 1.7 | 1.0 | (0.9) | 0.3 |
Foreign exchange movement | (39.6) | 77.4 | (36.2) | 77.4 |
At 31 March | 1,555.5 | 1,622.1 | 1,486.7 | 1,580.3 |
2024 | 2023 | |
£m | £m | |
Interest income on bank deposits | 21.6 | 15.5 |
21.6 | 15.5 |
2024 | 2023 | |
£m | £m | |
Financial assets | ||
Change in fair value of financial instruments designated at FVTPL | 933.5 | 167.6 |
Financial liabilities | ||
Change in fair value of financial instruments designated at FVTPL | (528.2) | 4.9 |
Net gains arising on investments | 405.3 | 172.5 |
2024 | 2023 | |
Finance costs | £m | £m |
Interest expense recognised on financial liabilities held at amortised cost | 42.2 | 57. 3 |
Arrangement and commitment fees | 4.6 | 4.7 |
Interest expense associated with lease obligations | 2.7 | 2.6 |
49.5 | 64.6 |
2024 | 2023 | |
£m | £m | |
Staff costs | 294.3 | 256.7 |
Amortisation and depreciation | 17.9 | 18.2 |
Operating lease expenses | 1.9 | 2.8 |
Auditor's remuneration | 2.4 | 2.3 |
2024 | 2023 | |
£m | £m | |
ICG Group | ||
Audit fees | ||
Group audit of the annual accounts | 1.7 | 1.5 |
Audit of subsidiaries' annual accounts | 0.3 | 0.3 |
Audit of controlled CLOs | 0.1 | 0.1 |
Total audit fees | 2.1 | 1.9 |
Non audit fees | ||
Audit-related assurance services | 0.2 | 0.3 |
Other assurance services | 0.1 | 0.1 |
Total non audit fees | 0.3 | 0.4 |
Total auditor's remuneration incurred by the Group | 2.4 | 2.3 |
2024 | 2023 | |
£m | £m | |
Directors’ emoluments | 5.1 | 4.9 |
Employee costs during the year including Directors: | ||
Wages and salaries | 253.4 | 228.7 |
Social security costs | 30.7 | 20.5 |
Pension costs | 10.2 | 7. 5 |
Total employee costs (note 11) | 294.3 | 256.7 |
The monthly average number of employees (including Executive Directors) was: | ||
Investment Executives | 289 | 268 |
Marketing and support functions | 350 | 293 |
Executive Directors | 3 | 3 |
642 | 564 |
2024 | 2023 | |
£m | £m | |
Current tax: | ||
Current year | 86.0 | 16.9 |
Prior year adjustment | 15.4 | (9.7) |
101.4 | 7.2 | |
Deferred tax: | ||
Current year | (28.1) | 14.1 |
Prior year adjustments | (10.9) | 8.1 |
(39.0) | 22.2 | |
Tax on profit on ordinary activities | 62.4 | 29.4 |
2024 | 2023 | |
£m | £m | |
Profit on ordinary activities before tax | 530.8 | 251.0 |
Tax at 25% (2023:19%) | 132.7 | 47.7 |
Effects of Prior year adjustment to current tax | 15.4 | (9.6) |
Prior year adjustment to deferred tax | (10.9) | 8.1 |
137.2 | 46.2 | |
Non-taxable and non-deductible items | 1.7 | (0.3) |
Non-taxable investment company income | (59.9) | (22.5) |
Trading income generated by overseas subsidiaries subject to different tax rates | (16.6) | 4.0 |
Deferred tax adjustment | – | 2.0 |
Tax charge for the period | 62.4 | 29.4 |
Share based | |||||
payments and | |||||
compensation | |||||
Deferred tax (asset)/liability | deductible as | Tax losses carried | Other temporary | ||
Investments | paid | forward | differences | Total | |
Group | £m | £m | £m | £m | £m |
As at 31 March 2022 | 36.1 | (38.1) | (2.0) | (5.9) | (9.9) |
Prior year adjustment | 2.0 | 0.2 | 2.2 | 5.2 | 9.6 |
Impact of changes to statutory tax rates | 0.3 | (1.1) | (0.7) | 1.1 | 0.6 |
Charge / (Credit) to equity | 2.2 | 3.4 | – | 1.0 | 5.6 |
Charge / (Credit) to income | 5.2 | (0.7) | 0.1 | 9.5 | 14.1 |
Movement in Foreign Exchange on retranslation | – | – | – | (0.4) | (0.4) |
Reclassification to current tax | – | – | – | (1.7) | (1.7) |
As at 31 March 2023 | 45.8 | (36.3) | (0.4) | 8.8 | 17.9 |
Reclassification between categories | 2.7 | 1.7 | – | (4.4) | – |
Reclassification of deferred tax liability out of discontinued operations | 14.0 | – | – | – | 14.0 |
Prior year adjustment | (4.1) | – | (1.6) | (5.2) | (10.9) |
Charge / (Credit) to equity | 0.2 | (6.9) | – | (6.7) | |
Charge / (Credit) to income | (11.4) | (10.0) | (5.3) | (1.4) | (28.1) |
Movement in foreign exchange on retranslation | – | – | – | (0.2) | (0.2) |
As at 31 March 2024 | 47.2 | (51.5) | (7.3) | (2.4) | (14.0) |
Share based | |||||
payments and | |||||
compensation | |||||
Deferred tax (asset)/liability | deductible as | Other temporary | |||
Investments | paid | Derivatives | differences | Total | |
Company | £m | £m | £m | £m | £m |
As at 31 March 2022 | 8.6 | (8.2) | (0.8) | (0.5) | (0.9) |
Prior year adjustment | – | – | – | 0.6 | 0.6 |
Impact of changes to statutory tax rates | 0.2 | (0.3) | 0.4 | 0.5 | 0.8 |
Charge / (Credit) to income | (0.5) | 0.2 | 1.6 | 1.1 | 2.4 |
As at 31 March 2023 | 8.3 | (8.3) | 1.2 | 1.7 | 2.9 |
Reclassification between categories | (0.4) | 0.3 | 0.2 | (0.1) | – |
Transfer | – | 8.0 | – | – | 8.0 |
Prior year adjustment | (1.0) | – | – | (1.7) | (2.7) |
Charge / (Credit) to income | (0.6) | – | (0.5) | 0.6 | (0.5) |
As at 31 March 2024 | 6.3 | – | 0.9 | 0.5 | 7.7 |
2024 | 2023 | |||
Per share pence | £m | Per share pence | £m | |
Ordinary dividends paid | ||||
Final | 52.2 | 149.5 | 57. 3 | 164.4 |
Interim | 25.8 | 73.9 | 25.3 | 72.0 |
78.0 | 223.4 | 82.6 | 236.4 | |
Proposed final dividend | 152.6 | 148.8 |
Year ended | Year ended | |
31 March 2024 | 31 March 2023 | |
Earnings | £m | £m |
Earnings for the purposes of basic and diluted earnings per share being net profit attributable to equity holders of the Parent | ||
Continuing operations | 467.4 | 221.6 |
Discontinued operations | 6.0 | 59.0 |
473.4 | 280.6 | |
Number of shares | ||
Weighted average number of ordinary shares for the purposes of basic earnings per share | 286,123,236 | 285,613,961 |
Effect of dilutive potential ordinary share options | 5,888,040 | 3,698,954 |
Weighted average number of ordinary shares for the purposes of diluted earnings per share | 292,011,276 | 289,312,915 |
Earnings per share for continuing operations 1 | ||
Basic, profit from continuing operations attributable to equity holders of the parent (pence) | 163.4p | 77.6p |
Diluted, profit from continuing operations attributable to equity holders of the parent (pence) | 160.1p | 76.6p |
Earnings per share for discontinued operations | ||
1 | ||
Basic, profit from discontinued operations attributable to equity holders of the parent (pence) | 2.1p | 20.6p |
Diluted, profit from discontinued operations attributable to equity holders of the parent (pence) | 2.0p | 20.4p |
Computer software | Goodwill | Investment management contracts | Total | |||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
Group | £m | £m | £m | £m | £m | £m | £m | £m |
Cost | ||||||||
At 1 April | 25.0 | 20.5 | 4.3 | 4.3 | 19.1 | 26.3 | 48.4 | 51.1 |
Reclassified | (0.8) | – | – | – | – | – | (0.8) | – |
Additions | 6.3 | 4.7 | – | – | – | – | 6.3 | 4.7 |
Derecognised | (12.5) | (0.3) | – | – | (18.3) | (7.1) | (30.8) | (7.4) |
Exchange differences | (0.1) | 0.1 | – | – | 0.3 | (0.1) | 0.2 | – |
At 31 March | 17.9 | 25.0 | 4.3 | 4.3 | 1.1 | 19.1 | 23.3 | 48.4 |
Amortisation | ||||||||
At 1 April | 16.4 | 12.4 | – | – | 17.1 | 21.6 | 33.5 | 34.0 |
Charge for the year | 3.4 | 4.0 | – | – | 2.2 | 2.7 | 5.6 | 6.7 |
Derecognised | (12.5) | – | – | (18.3) | (7.2) | (30.8) | (7.2) | |
At 31 March | 7.3 | 16.4 | – | – | 1.0 | 17.1 | 8.3 | 33.5 |
Net book value | 10.6 | 8.6 | 4.3 | 4.3 | 0.1 | 2.0 | 15.0 | 14.9 |
Computer software | Investment management contracts | Total | |||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | ||
Company | £m | £m | £m | £m | £m | £m | |
Cost | |||||||
At 1 April | 23.8 | 20.4 | 18.3 | 19.9 | 42.1 | 40.3 | |
Additions | 6.2 | 3.6 | – | – | 6.2 | 3.6 | |
Derecognised | (12.9) | (0.2) | (18.3) | (1.6) | (31.2) | (1.8) | |
At 31 March | 17.1 | 23.8 | – | 18.3 | 17.1 | 42.1 | |
Amortisation | |||||||
At 1 April | 16.5 | 12.5 | 16.4 | 15.7 | 32.9 | 28.2 | |
Charge for the year | 3.4 | 4.0 | 1.9 | 2.3 | 5.3 | 6.3 | |
Derecognised | (12.5) | – | (18.3) | (1.6) | (30.8) | (1.6) | |
At 31 March | 7.4 | 16.5 | – | 16.4 | 7.4 | 32.9 | |
Net book value | 9.7 | 7. 3 | – | 1.9 | 9.7 | 9.2 |
Furniture and equipment | ROU asset | Leasehold improvements | Total | |||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
Group | £m | £m | £m | £m | £m | £m | £m | £m |
Cost | ||||||||
At 1 April | 7. 5 | 4.5 | 90.0 | 67.7 | 14.7 | 11.3 | 112.2 | 83.5 |
Reclassified | – | – | – | – | 0.8 | – | 0.8 | – |
Additions | 1.3 | 3.1 | 1.2 | 33.8 | 1.9 | 3.4 | 4.4 | 40.3 |
Disposals | (2.9) | (0.4) | (1.2) | (11.7) | (0.6) | – | (4.7) | (12.1) |
Exchange differences | – | 0.3 | (0.9) | 0.2 | – | – | (0.9) | 0.5 |
At 31 March | 5.9 | 7. 5 | 89.1 | 90.0 | 16.8 | 14.7 | 111.8 | 112.2 |
Depreciation | ||||||||
At 1 April | 4.2 | 2.9 | 16.8 | 18.2 | 3.0 | 2.0 | 24.0 | 23.1 |
Charge for the year | 1.7 | 1.4 | 9.2 | 9.1 | 1.5 | 1.0 | 12.4 | 11.5 |
Disposals | (3.1) | (0.1) | (0.3) | (10.5) | (0.4) | – | (3.8) | (10.6) |
At 31 March | 2.8 | 4.2 | 25.7 | 16.8 | 4.1 | 3.0 | 32.6 | 24.0 |
Net book value | 3.1 | 3.3 | 63.4 | 73.2 | 12.7 | 11.7 | 79.2 | 88.2 |
Furniture and equipment | ROU asset | Leasehold improvements | Total | |||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
Company | £m | £m | £m | £m | £m | £m | £m | £m |
Cost | ||||||||
At 1 April | 3.1 | 2.8 | 47. 5 | 50.1 | 9.9 | 9.5 | 60.5 | 62.4 |
Additions | 0.3 | 0.3 | – | – | 0.3 | 0.4 | 0.6 | 0.7 |
Disposals | (2.3) | – | – | (2.6) | – | – | (2.3) | (2.6) |
At 31 March | 1.1 | 3.1 | 47. 5 | 47. 5 | 10.2 | 9.9 | 58.8 | 60.5 |
Depreciation | ||||||||
At 1 April | 2.4 | 1.6 | 12.2 | 9.8 | 1.9 | 1.1 | 16.5 | 12.5 |
Charge for the year | 0.4 | 0.8 | 4.2 | 4.0 | 1.0 | 0.8 | 5.6 | 5.6 |
Disposals | (2.3) | – | – | (1.6) | – | – | (2.3) | (1.6) |
At 31 March | 0.5 | 2.4 | 16.4 | 12.2 | 2.9 | 1.9 | 19.8 | 16.5 |
Net book value | 0.6 | 0.7 | 31.1 | 35.3 | 7. 3 | 8.0 | 39.0 | 44.0 |
2024 | 2023 | |
Group | £m | £m |
Within one year | 0.4 | 0.4 |
After one year but not more than five years | 0.4 | 0.8 |
At 31 March | 0.8 | 1.2 |
2024 | 2023 | |
Group | £m | £m |
Investment property at fair value | ||
At 1 April | 0.8 | 1.5 |
Additions | 51.9 | – |
Reclassified | 54.5 | – |
Fair value loss | (24.5) | (0.7) |
At 31 March | 82.7 | 0.8 |
Group | Company | |||
2024 | 2023 | 2024 | 2023 | |
£m | £m | £m | £m | |
Trade and other receivables within structured entities controlled by the Group | 107.6 | 43.7 | – | – |
Trade and other receivables excluding those held in structured entities controlled by the Group | 240.2 | 178.3 | 27.8 | 33.2 |
Amount owed by Group companies | – | – | 0.9 | 169.2 |
Prepayments | 41.8 | 10.0 | 8.6 | 8.1 |
Total current assets | 389.6 | 232.0 | 37. 3 | 210.5 |
Non-current assets | ||||
Trade and other receivables excluding those held in structured entities controlled by the Group | 36.1 | 37.1 | 24.3 | 7.6 |
Amounts owed by Group companies | – | – | 734.4 | 758.7 |
Total non-current assets | 36.1 | 37.1 | 758.7 | 766.3 |
Group | Company | |||
2024 | 2023 | 2024 | 2023 | |
£m | £m | £m | £m | |
Trade and other payables within structured entities controlled by the Group | 316.3 | 328.1 | – | |
Trade and other payables excluding those held in structured entities controlled by the Group | 209.6 | 140.2 | 19.5 | 121.2 |
Amounts owed to Group companies | – | – | 1,098.9 | 1,035.0 |
Social security tax | 3.3 | 3.1 | 2.4 | 2.5 |
Total current trade and other payables | 529.2 | 471.4 | 1,120.8 | 1,158.7 |
Non-current liabilities | ||||
Trade and other payables excluding those held in structured entities controlled by the Group | 66.0 | 71.1 | 0.3 | 71.3 |
Total non-current trade and other payables | 66.0 | 71.1 | 0.3 | 71.3 |
2024 | 2023 | |||||
Floating | Fixed | Total | Floating | Fixed | Total | |
£m | £m | £m | £m | £m | £m | |
Financial assets (excluding investments in loans held in consolidated entities) | 839.5 | 3,023.4 | 3,862.9 | 744.4 | 3,049.1 | 3,793.5 |
Investments in loans held in consolidated entities | 4,762.4 | 319.9 | 5,082.3 | 4,901.1 | 253.9 | 5,155.0 |
Financial liabilities (excluding borrowings and loans held in consolidated entities) | – | (1,734.6) | (1,734.6) | – | (1,929.2) | (1,929.2) |
Borrowings and loans held in consolidated entities | (4,688.9) | (391.2) | (5,080.1) | (4,706.6) | (371.5) | (5,078.1) |
913.0 | 1,217.5 | 2,130.5 | 938.9 | 1,002.3 | 1,941.2 |
2024 | |||||
Net statement of | Forward | ||||
financial Position | exchange | Sensitivity to | Increase in net | ||
exposure | contracts | Net exposure | strengthening | assets | |
Market risk - Foreign exchange risk | £m | £m | £m | % | £m |
Sterling | 401.7 | 1,121.1 | 1,522.8 | – | – |
Euro | 804.0 | (450.7) | 353.3 | 15% | 53.0 |
US dollar | 710.3 | (492.1) | 218.2 | 20% | 43.6 |
Other currencies | 206.7 | (178.2) | 28.5 | 10-25% | – |
2,122.7 | 0.1 | 2,122.8 | – | 96.6 |
2023 | |||||
Net statement of | Forward | ||||
financial Position | exchange | Sensitivity to | Increase in net | ||
exposure | contracts | Net exposure | strengthening | assets | |
£m | £m | £m | % | £m | |
Sterling | 726.8 | 772.7 | 1,499.5 | – | – |
Euro | 552.0 | (259.3) | 292.7 | 15% | 43.9 |
US dollar | 564.5 | (324.9) | 239.6 | 20% | 47.9 |
Other currencies | 195.6 | (182.2) | 13.4 | 10-25% | – |
2,038.9 | 6.3 | 2,045.2 | – | 91.8 |
Contractual maturity analysis | |||||
Less than one | One to two | Two to five y | More than five | ||
year | years | ears | years | Total | |
As at 31 March 2024 | £m | £m | £m | £m | £m |
Financial liabilities | |||||
Private placements | 267.0 | 194.7 | 185.2 | – | 646.9 |
Listed notes and bonds | 17.6 | 17.6 | 466.5 | 438.1 | 939.8 |
Debt issued by controlled structured entities | 576.8 | 262.6 | 2,065.3 | 4,362.8 | 7,267.5 |
Derivative financial instruments | 0.9 | (4.8) | – | – | (3.9) |
Lease liabilities | 10.8 | 10.4 | 30.1 | 34.6 | 85.9 |
Other financial liabilities | 9.2 | 1.4 | 23.2 | 0.0 | 33.8 |
882.3 | 481.9 | 2,770.3 | 4,835.5 | 8,970.0 |
Contractual maturity analysis | |||||
Less than one | One to two | Two to five | More than five | ||
year | years | years | years | Total | |
As at 31 March 2023 | £m | £m | £m | £m | £m |
Financial liabilities | |||||
Private placements | 78.2 | 273.5 | 282.2 | 106.7 | 740.6 |
Listed notes and bonds | 18.1 | 18.1 | 486.8 | 461.5 | 984.5 |
Debt issued by controlled structured entities | 176.3 | 204.6 | 2,430.4 | 3,748.0 | 6,559.3 |
Derivative financial instruments | (1.6) | (3.1) | (4.4) | – | (9.1) |
Lease liabilities | 8.5 | 11.3 | 32.0 | 46.1 | 97.9 |
279.5 | 504.4 | 3,227.0 | 4,362.3 | 8,373.2 |
Group | Company | |||
2024 | 2023 | 2024 | 2023 | |
£m | £m | £m | £m | |
Investment in private and public companies | 406.2 | 267.3 | 87.1 | 86.1 |
Investment in managed funds | 2,310.0 | 2,153.4 | 134.2 | 178.8 |
Non-consolidated CLOs and credit funds | 131.0 | 113.3 | 21.8 | 23.8 |
Consolidated CLOs and credit funds | 4,617.5 | 4,669.1 | – | – |
Derivatives assets | 9.3 | 22.0 | 9. 3 | 22.0 |
Investment in joint venture | – | 5.8 | – | – |
Total financial assets at fair value | 7,474.0 | 7,230.9 | 252.4 | 310.7 |
Number of | |||
ordinary | |||
shares of 26¼p | |||
allotted, | |||
called up and | Share Capital | Share Premium | |
Group and Company | fully paid | £m | £m |
1 April 2023 | 294,332,182 | 77. 3 | 180.9 |
Shares issued | 33,144 | – | 0.4 |
31 March 2024 | 294,365,326 | 77. 3 | 181.3 |
Number of | |||
ordinary | |||
shares of 26¼p | |||
allotted, | |||
called up and | Share Capital | Share Premium | |
Group and Company | fully paid | £m | £m |
1 April 2022 | 294,285,804 | 77. 3 | 180.3 |
Shares issued | 46,378 | – | 0.6 |
31 March 2023 | 294,332,182 | 77. 3 | 180.9 |
2024 | 2023 | 2024 | 2023 | |
£m | £m | Number | Number | |
1 April | 103.4 | 93 | 9,249,895 | 7,734,849 |
Purchased (ordinary shares of 26¼p) | – | 38.9 | – | 3,000,000 |
Options/awards exercised | (24.2) | (28.5) | (1,583,032) | (1,484,954) |
As at 31 March | 79.2 | 103.4 | 7,666,863 | 9,249,895 |
Number | Weighted average fair value | |||
Deferred share awards | 2024 | 2023 | 2024 | 2023 |
Outstanding at 1 April | 2,964,516 | 2,470,280 | 15.75 | 16.52 |
Granted | 2,316,207 | 1,811,061 | 13.35 | 14.27 |
Vested | (1,476,697) | (1,316,825) | 15.62 | 15.00 |
Outstanding as at 31 March | 3,804,026 | 2,964,516 | 14.35 | 15.75 |
Number | Weighted average fair value | |||
PLC Equity awards | 2024 | 2023 | 2024 | 2023 |
Outstanding at 1 April | 2,142,252 | 2,139,210 | 12.2 | 10.3 |
Granted | 982,261 | 777,577 | 13.4 | 14.3 |
Vested | 471,806 | (774,535) | 12.2 | 9.8 |
Outstanding as at 31 March | 3,596,319 | 2,142,252 | 14.7 | 12.2 |
Number | Weighted average fair value | |||
Special Recognition Awards | 2024 | 2023 | 2024 | 2023 |
Outstanding as at 1 April | 46,154 | – | 14.27 | – |
Granted | – | 46,154 | 0.00 | 14.27 |
Vesting | (46,154) | – | 14.27 | – |
Outstanding as at 31 March | – | 46,154 | – | 14.27 |
Number | Weighted average fair value | |||
Buy Out Awards | 2024 | 2023 | 2024 | 2023 |
Outstanding as at 1 April | 1,097,088 | 155,940 | 12.96 | 12.85 |
Granted | 180,336 | 1,307,916 | 14.46 | 12.68 |
Vesting | (468,121) | (366,768) | 13.55 | 13.35 |
Outstanding as at 31 March | 809,303 | 1,097,088 | 13.41 | 12.96 |
Number | Weighted average fair value | |||
Save As You Earn | 2024 | 2023 | 2024 | 2023 |
Outstanding as at 1 April | 103,818 | 199,737 | 5.0 | 4.5 |
Granted | 197,452 | – | 4.0 | – |
Vesting | (32,851) | (46,378) | 3.3 | 3.3 |
Forfeited | (46,298) | (49,541) | 5.5 | 4.3 |
Outstanding as at 31 March | 222,121 | 103,818 | 4.3 | 5.0 |
Number | Weighted average fair value | |||
Growth Incentive Award | 2024 | 2023 | 2024 | 2023 |
Outstanding as at 1 April | 463,000 | – | 3.13 | – |
Granted | – | 480,000 | – | 3.13 |
Vesting | – | – | – | – |
Forfeited | (52,000) | (17,000) | 3.13 | – |
Outstanding as at 31 March | 411,000 | 463,000 | 3.13 | 3.13 |
2024 | 2023 | |
£m | £m | |
ICG Europe Fund V | 24.2 | 29.9 |
ICG Europe Fund VI | 79.8 | 82.0 |
ICG Europe Fund VII | 105.2 | 111.7 |
ICG Europe Fund VIII | 192.4 | 185.5 |
ICG Mid-Market Fund | 14.3 | 25.1 |
ICG Mid-Market Fund II | 64.1 | – |
Intermediate Capital Asia Pacific Fund III | 60.7 | 45.4 |
ICG Asia Pacific Fund IV | 52.3 | 93.5 |
ICG Strategic Secondaries Fund II | 32.1 | 33.1 |
ICG Strategic Equity Fund III | 95.9 | 72.3 |
ICG Strategic Equity Fund IV | 35.6 | 38.8 |
ICG Strategic Equity Fund V | 79.2 | – |
ICG Recovery Fund II | 40.8 | 34.3 |
LP Secondaries | 20.8 | 47.4 |
ICG Senior Debt Partners II | 4.0 | 3.8 |
ICG Senior Debt Partners III | 5.1 | 5.8 |
ICG Senior Debt Partners IV | 6.7 | 7. 3 |
Senior Debt Partners V | 26.6 | 42.3 |
Senior Debt Partners NYCERS | 1.6 | – |
ICG North American Private Debt Fund | 26.9 | 27. 5 |
ICG North American Private Debt Fund II | 24.6 | 27.9 |
ICG North American Credit Partners III | 79.2 | 38.1 |
ICG-Longbow UK Real Estate Debt Investments V | 0.2 | 0.2 |
ICG-Longbow UK Real Estate Debt Investments VI | 12.4 | 13.9 |
ICG-Longbow Development Fund | 6.8 | 6.8 |
ICG Living | 20.9 | 21.8 |
ICG Infrastructure Equity Fund I | 31.7 | 59.8 |
ICG Infrastructure Equity Fund II | 10.1 | – |
ICG Private Markets Pooling - Sale and Leaseback | 18.4 | 35.9 |
ICG Sale & Leaseback II | 16.5 | 17.00 |
ICG Metropolitan 2 | 36.8 | – |
1,225.9 | 1,107.1 |
2024 | 2023 | |
£m | £m | |
Income statement | ||
Net gains/(losses) on investments | 84.5 | (17.2) |
84.5 | (17.2) |
2024 | 2023 | |
£m | £m | |
Statement of financial position | ||
Trade and other receivables | 179.2 | 66.8 |
Trade and other payables | (155.0) | (52.3) |
24.2 | 14.5 |
2024 | 2023 | |
£m | £m | |
Income statement | ||
Management fees | 502.5 | 473.5 |
Performance fees | 75.7 | 19.4 |
Dividend income | – | 0.1 |
578.2 | 493.0 |
2024 | 2023 | |
£m | £m | |
Statement of financial position | ||
Performance fees receivable | 83.7 | 37. 5 |
Trade and other receivables | 848.1 | 781.9 |
Trade and other payables | (807.4) | (718.3) |
124.4 | 101.1 |
2024 | 2023 | |
£m | £m | |
Short-term employee benefits | 3.7 | 3.7 |
Post-employment benefits | 0.2 | 0.1 |
Other long-term benefits | 0.2 | 0.9 |
Share-based payment benefits | 6.9 | 7.0 |
11.0 | 11.7 |
2024 | 2023 | |
£000 | £000 | |
William Rucker | 375.0 | 63.9 |
Andrew Sykes | 120.0 | 290.5 |
Rosemary Leith | 134.5 | 113.9 |
Matthew Lester | 120.5 | 116.5 |
Virginia Holmes | 120.5 | 120.5 |
Stephen Welton | 90.5 | 90.5 |
Amy Schioldager | 125.0 | 125.0 |
Rusty Nelligan | 104.5 | 108.5 |
Kathryn Purves | – | 134.5 |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG Asset Management Limited | United Kingdom | Holding company | Ordinary shares | 100% | |
ICG FMC Limited | England & Wales | Holding company | Ordinary shares | 100% | |
Intermediate Capital Investments Limited | England & Wales | Investment company | Ordinary shares | 100% | |
ICG Global Investment UK Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG Carbon Funding Limited | England & Wales | Investment company | Ordinary shares | 100% | |
ICG Longbow Richmond Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG-Longbow BTR Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG Japan (Funding 2)Limited | England & Wales | Holding company | Ordinary shares | 100% | |
ICG Longbow Development (Brighton)Limited | England & Wales | Holding company | Ordinary shares | 100% | |
LREC Partners Investments No. 2 Limited | England & Wales | Investment company | Ordinary shares | 55% | |
ICG Longbow Senior Debt I GP Limited | England & Wales | General partner | Ordinary shares | 100% | |
ICG Debt Advisors (Cayman) Ltd | 4 | Cayman Islands | Advisory company | Ordinary shares | 100% |
ICG Re Holding (Germany) GmbH | 9 | Germany | Special purpose vehicle | Ordinary shares | 100% |
ICG Watch Jersey GP Limited | 19 | Jersey | General partner | Ordinary shares | 100% |
Intermediate Investments Jersey Limited | 19 | Jersey | Investment company | Ordinary shares | 100% |
Intermediate Capital Group Espana SL | 33 | Spain | Advisory company | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG Alternative Investment Limited | England & Wales | Advisory company | Ordinary shares | 100% | |
Intermediate Capital Managers Limited | England & Wales | Advisory company | Ordinary shares | 100% | |
Intermediate Capital Asia Pacific Limited | 12 | Hong Kong | Advisory company | Ordinary shares | 100% |
ICG Europe S.à r.l. | 23 | Luxembourg | Advisory company | Ordinary shares | 100% |
ICG Enterprise Co-Investment GP Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG-Longbow B Investments L.P. | England & Wales | Investment company | N/A | 50% | |
ICG-Longbow Development GP LLP | England & Wales | General Partner | N/A | –% | |
Longbow Real Estate Capital LLP | England & Wales | Advisory company | N/A | –% | |
ICG Senior Debt Partners UK GP Limited | England & Wales | General Partner | Ordinary shares | 100% | |
Intermediate Capital Group SAS | 8 | France | Advisory company | Ordinary shares | 100% |
ICG Nordic AB | 34 | Sweden | Advisory company | Ordinary shares | 100% |
Intermediate Capital Group Dienstleistungsgesellschaft mbH | 9 | Germany | Service company | Ordinary shares | 100% |
Intermediate Capital Group Benelux B.V. | 30 | Netherlands | Advisory company | Ordinary shares | 100% |
Intermediate Capital Group Inc. | 17 | United States | Advisory company | Ordinary shares | 100% |
Intermediate Capital GP 2003 Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital GP 2003 No.1 Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Asia Pacific Mezzanine 2005 GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Asia Pacific Mezzanine Opportunity 2005 GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Asia Pacific 2008 GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Europe Fund V GP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Group Beratungsgesellschaft GmbH | 9 | Germany | Advisory company | Ordinary shares | 100% |
Intermediate Capital Group (Singapore) Pte. Limited | 32 | Singapore | Advisory company | Ordinary shares | 100% |
ICG North America Associates LLC | 17 | Delaware | General Partner | Ordinary shares | 100% |
ICG Japan KK | 14 | Japan | Advisory company | Ordinary shares | 100% |
ICG Asia Pacific Fund III GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Alternative Credit (Luxembourg)GPS.A. | 25 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Alternative Credit (Cayman) GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Senior Debt Partners | 28 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Secondaries Carbon Associates LLC | 17 | Delaware | General Partner | Ordinary shares | 100% |
ICG European Fund 2006 B GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Europe Fund VI GP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
ICG Total Credit (Global) GP, S.à r.l. | 24 | Luxembourg | General Partner | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG EFV MLP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
ICG-Longbow IV GP S.à r.l. | 20 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Fund VI Lux GP S.à r.l. | 20 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Centre Street Partnership GP Limited | 18 | Jersey | General Partner | Ordinary shares | 100% |
Intermediate Capital Group Polska Sp. z.o.o | 31 | Poland | Service company | Ordinary shares | 100% |
ICG Recovery Fund 2008 B GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Europe Fund VII GP S.à r.l. | 28 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG - Longbow Fund V GP S.à r.l. | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Private Markets GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Mid-Market Fund GP S.à r.l. | 28 | Luxembourg | General Partner | Ordinary shares | 100% |
Intermediate Capital Inc | 17 | Delaware | Dormant | Ordinary shares | 100% |
ICG MF 2003 No.1 EGP 1 Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG MF 2003 No.1 EGP 2 Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG MF 2003 No. 3 EGP 1 Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG MF 2003 No.3 EGP 2 Limited | England & Wales | General Partner | Ordinary shares | 100% | |
ICG Private Credit GP S.à r.l. | 28 | Luxembourg | General Partner | Ordinary shares | 100% |
Intermediate Capital Group (Italy) S.r.l | 13 | Italy | Advisory company | Ordinary shares | 100% |
ICG-LONGBOW SENIOR GP LLP | England & Wales | General Partner | N/A | –% | |
ICG Alternative Credit Warehouse Fund I GP, LLC | 17 | Delaware | General Partner | Ordinary shares | 100% |
ICG Alternative Credit (Jersey)GPLimited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Enterprise Carry GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Senior Debt Partners Performance GP Limited | 19 | Jersey | General Partner | Ordinary shares | 100% |
ICG Structured Special Opportunities GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Asia Pacific Fund IV GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG European Credit Mandate GP S.à r.l. | 28 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Infrastructure Equity Fund I GP S.a.r.l | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG LP Secondaries Fund Associates I S.a. r.l. | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG US Senior Loan Fund GP Ltd | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Recovery Fund II GP S.à r.l. | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity IV GP LP | 16 | Delaware | Limited Partner | N/A | –% |
ICG North American Private Debt (Offshore) GP Limited Partnership | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Europe Fund VI GP Limited Partnership | 18 | Jersey | Limited Partner | N/A | –% |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG Strategic Secondaries Carbon (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Strategic Secondaries II (Offshore)GPLP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Strategic Secondaries II GP LP | 16 | Delaware | Limited Partner | N/A | –% |
ICG North American Private Debt II GP LP | 17 | Delaware | Limited Partner | N/A | –% |
ICG North American Private Debt II (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Japan Cayman Performance GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Side Car GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Strategic Equity III (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Australian Senior Debt GP Limited | 5 | Cayman Islands | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Side Car (Onshore) GP LP | 16 | Delaware | Limited Partner | N/A | –% |
ICG Europe Fund VIII GP S.à r.l. | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG North American Private Equity I GP LP | 21 | Delaware | Limited Partner | N/A | –% |
ICG Real Estate Debt VI GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Excelsior GP S.à r.l. | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Life Sciences GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Associates IV S.à r.l | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity IV GP LP SCSp | 29 | Luxembourg | Limited Partner | N/A | –% |
ICG RE AUSTRALIA GROUP PTY LTD | 3 | Australia | Service company | Ordinary shares | 100% |
ICG (DIFC) Limited | 26 | United Arab Emirates | Service company | Ordinary shares | 100% |
ICG Metropolitan GP S.à r.l. | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Senior Debt Partners GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Real Estate Senior Debt V GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG SRE GP II S.à r.l. | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Living GP S.a r.l. | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Europe Mid-Market Fund II GP S.à r.l. | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Infrastructure Fund II GP S.à r.l | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity GP V S.à r.l. | 29 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Fund Advisors LLC | 17 | Delaware | Advisory company | Ordinary shares | 100% |
ICG Alternative Credit LLC | 17 | Delaware | Advisory company | Ordinary shares | 100% |
ICG Strategic Equity Advisors LLC | 17 | Delaware | Advisory company | Ordinary shares | 100% |
ICG Debt Administration LLC | 17 | Delaware | Service company | Ordinary shares | 100% |
ICG Strategic Equity Associates II LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG Velocity Co-Investor Associates LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
ICG Debt Advisors LLC - Manager Series | 17 | Delaware | Advisory company | Ordinary shares | 100% |
ICG North America Associates II LLC | 17 | Delaware | General Partner | Ordinary shares | 100% |
ICG Strategic Equity Associates III LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
ICG Augusta Associates LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
ICG STRATEGIC EQUITY ASSOCIATES IV LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
ICG LP Secondaries Associates I LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
ICG North America Associates III LLC | 17 | United States | General Partner | Ordinary shares | 100% |
ICG Global Investment Jersey Limited | 18 | Jersey | Investment company | Ordinary shares | 100% |
ICG North America Holdings Limited | 5 | Cayman Islands | Investment company | Ordinary shares | 100% |
ICG Global Nominee Jersey Limited | 18 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG Global Nominee Jersey 2 Limited | 18 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG RE CORPORATE AUSTRALIA PTY LTD | 3 | Australia | Service company | Ordinary shares | 100% |
ICG RE CAPITAL PARTNERS AUSTRALIA PTY LTD | 3 | Australia | Advisory company | Ordinary shares | 100% |
ICG RE FUNDS MANAGEMENT AUSTRALIA PTY LTD | 3 | Australia | Service company | Ordinary shares | 100% |
Intermediate Capital Managers (Australia)PTY Limited | 2 | Australia | Advisory company | Ordinary shares | 100% |
Intermediate Capital Australia PTY Limited | 1 | Australia | Advisory company | Ordinary shares | 100% |
ICG Alternative Investment (Netherlands) B.V. | 30 | Netherlands | Advisory company | Ordinary shares | 100% |
ICG Asia Pacific Fund IV GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | –% |
ICG Augusta GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG NA Debt Co-Invest Limited | 15 | England & Wales | Investment company | Ordinary shares | 100% |
ICG Debt Advisors LLC – Holdings Series | 17 | Delaware | Investment company | Ordinary shares | 100% |
ICG EFV MLP GP LIMITED | England & Wales | General Partner | Ordinary shares | 100% | |
ICG Europe Fund VII GP LP SCSp | 28 | Luxembourg | Limited Partner | N/A | –% |
ICG Europe Fund VIII GP LP SCSp | 29 | Luxembourg | Limited Partner | N/A | –% |
ICG Europe Mid-Market Fund GP LP SCSp | 28 | Luxembourg | Limited Partner | N/A | –% |
ICG European Credit Mandate GP LP SCSp | 28 | Luxembourg | Limited Partner | N/A | –% |
ICG EXCELSIOR GP LP SCSp | 29 | Luxembourg | Limited Partner | N/A | –% |
ICG Executive Financing Limited | 19 | Jersey | Service company | Ordinary shares | 100% |
ICG Infrastructure Equity Fund I GP LP SCSp | 29 | Luxembourg | Limited Partner | N/A | –% |
ICG Life Sciences GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | –% |
Avanton Richmond Developments Limited | 7 | England & Wales | Special purpose vehicle | Ordinary shares | 70% |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG LP Secondaries I GP LP SCSp | 29 | Luxembourg | Limited Partner | N/A | –% |
ICG Employee Benefit Trust 2015 | 11 | Guernsey | N/A | Ordinary shares | 100% |
ICG Private Markets General Partner SCSp | 27 | Luxembourg | General Partner | N/A | –% |
ICG Real Estate Debt VI GP LP SCSp | 27 | Luxembourg | Limited Partner | N/A | –% |
ICG Recovery Fund II GP LP SCSp | 29 | Luxembourg | Limited Partner | N/A | –% |
ICG Strategic Equity Side Car II GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
ICG Strategic Equity Side Car II (Onshore) GP LP | 16 | Delaware | Limited Partner | N/A | –% |
ICG Velocity GP LP | 16 | Delaware | Limited Partner | N/A | –% |
ICG Velocity Co-Investor GP LP | 16 | Delaware | Limited Partner | N/A | –% |
ICG Velocity Co-Investor (Offshore) GP LP | 5 | Cayman Islands | Limited Partner | N/A | –% |
Wise Living Homes Limited | 6 | England & Wales | Special purpose vehicle | Ordinary shares | 83% |
Wise Limited Amber Langley Mill Limited | 6 | United Kingdom | Special purpose vehicle | Ordinary shares | 83% |
ICG Longbow Development Debt Limited | England & Wales | Investment company | Ordinary shares | 100% | |
ICG-Longbow Investment 3 LLP | England & Wales | Special purpose vehicle | N/A | –% | |
ICG Asia Pacific Fund III GP Limited Partnership | 19 | Jersey | Limited Partner | N/A | –% |
ICG Europe Fund V GP Limited Partnership | 18 | Jersey | Limited Partner | N/A | –% |
ICG Europe Copenhagen, filial af ICG Europe S.à r.l. | 35 | Denmark | Branch | N/A | 100% |
ICG Europe SARL - Frankfurt Branch | 36 | Germany | Branch | N/A | 100% |
ICG Europe SARL - Milan Branch | 37 | Italy | Branch | N/A | 100% |
ICG Europe SARL - Paris Branch | 38 | France | Branch | N/A | 100% |
ICG North America Associates III S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG North American Private Debt GP LP | 17 | Delaware | Limited Partner | N/A | –% |
ICG Real Estate Opportunities APAC GP S.à r.l. | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Strategic Equity GP V LLC | 16 | Delaware | General Partner | Ordinary shares | 100% |
Intermediate Capital Managers Limited (France Branch) | 38 | France | Branch | N/A | 100% |
ICG Infrastructure APAC I GP S.à r.l. | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
Rock Investments GP S.à r.l. | 27 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Real Estate Debt VII GP Sarl | 22 | Luxembourg | General Partner | Ordinary shares | 100% |
ICG Seed Asset Founder LP Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG North American Private Equity Debt Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG Real Estate E Debt Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
ICG Life Sciences Debt Limited | 19 | Jersey | Special purpose vehicle | Ordinary shares | 100% |
% Voting rights | |||||
Name | Ref | Country of incorporation | Principal activity | Share class | held |
ICG North American Private Equity Associates I LLC | 21 | Delaware | General Partner | Ordinary shares | 100% |
ICG North American Private Equity Fund I LP | 21 | Delaware | Special purpose vehicle | N/A | –% |
ICG Life Sciences SCSp | 27 | Luxembourg | Limited Partner | N/A | –% |
ICG Life Sciences Feeder SCSp | 27 | Luxembourg | Special purpose vehicle | N/A | –% |
ICG Funding Lux S.à r.l. | 22 | Luxembourg | Special purpose vehicle | Ordinary shares | 100% |
Atlanta Investment PTE. Limited | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
ICG Infrastructure APAC Fund SCSp | 22 | Luxembourg | Special purpose vehicle | N/A | –% |
ICG Infrastructure APAC Investment PTE. Limited | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero PTE Ltd | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
ICG Real Estate Opportunities APAC Fund SCSP | 22 | Luxembourg | Special purpose vehicle | N/A | –% |
Yangju Investment PTE. LTD. | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero Japan Master Pte. Ltd | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero Cruise JP 1 Pte. Ltd | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Montero Cruise JP 2 Pte. Ltd | 10 | Singapore | Special purpose vehicle | Ordinary shares | 100% |
Capstone Living and Stay General Private Investment Company No. 1 | 0 | South Korea | Portfolio Company | Ordinary shares | 100% |
Capstone Living and Stay General Private Investment Company No. 2 | 0 | South Korea | Portfolio Company | Ordinary shares | 100% |
Rifa Private Real Estate Trust No. 24 | 0 | South Korea | Portfolio Company | Ordinary shares | 100% |
Registered offices | |
1 | Level 18, 88 Phillip Street, Sydney, NSW 2000, Australia |
2 | Level 31, 88 Phillip Street, Sydney, NSW 2000, Australia |
3 | Level 9, 88 Phillip Street, Sydney, NSW 2000, Australia |
4 | 75 Fort Street, Clifton House, c/o Estera Trust (Cayman)Limited,PO Box 1350, Grand Cayman, KY1-1108, Cayman Islands |
5 | PO Box 309, Ugland House, C/o Maples Corporate Services Limited, Grand Cayman, KY1-1104, Cayman Islands |
6 | 17 Regan Way, Chetwynd Business Park, Chilwell, Nottingham, NG9 6RZ, England & Wales |
7 | Brock House, 19 Langham Street, London, England, W1W 6BP |
8 | 1 rue de la Paix, Paris, 75002, France |
9 | 12th Floor, An der Welle 5, Frankfurt, 60322, Germany |
10 | 9 Temasek Boulevard, #12-01/02. Suntec Tower Two, 038989, Singapore |
11 | c/o Zedra Trust Company (Guernsey)Limited,3rd Floor, Cambridge House, Le Truchot, St Peter Port, GY1 1WD, Guernsey |
12 | Suites 1301-02, 13/F, AIA Central, 1 Connaught Road Central, Hong Kong |
13 | Corso Giacomo Matteotti 3, Milan, 20121, Italy |
14 | Level 23, Otemachi Nomura Building, 2-1-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan |
15 | 25 Farringdon Street, London, EC4A 4AB |
16 | c/o Maples Fiduciary Services (Delaware) Inc., Suite 302, 4001 Kennett Pike, Wilmington, DE, 19807, United States |
17 | c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, DE, 19801, United States |
18 | IFC 1, The Esplanade, St. Helier, JE1 4BP, Jersey |
19 | Ogier House,44 The Esplanade, St. Helier, JE4 9WG, Jersey |
20 | 12E, rue Guillaume Kroll, L - 1882 Luxembourg |
21 | c/o Intertrust Corporate Services Delaware LTD, Suite 210, 200 Bellevue Parkway, Wilmington, DE, 19809, United States |
22 | 3, rue Gabriel Lippmann, L - 5365 Munsbach, Luxembourg |
23 | 32-36, boulevard d'Avranches L - 1160 Luxembourg, 1160, Luxembourg |
24 | 49 Avenue John F. Kennedy, Luxembourg, L-1855, Luxembourg |
25 | 5 Allée Scheffer, Luxembourg, L-2520, Luxembourg |
26 | Index Tower, Floor 4, Unit 404, Dubai International Financial Centre, Dubai, United Arab Emirates |
27 | 6, rue Eugene Ruppert, Luxembourg, L-2453, Luxembourg |
28 | 60, Avenue J.F. Kennedy, Luxembourg, L-1855, Luxembourg |
29 | 6H Route de Trèves, Senningerberg, L-2633, Luxembourg |
30 | Paulus Potterstraat 20, 2hg., Amsterdam, 1071 DA, Netherlands |
31 | Spark B, Aleja Solidarności 171, Warsaw, 00-877, Poland |
32 | 8 Marina View, #32-06. Asia Square Tower 1, 018960, Singapore |
33 | Serrano 30-3º, 28001 Madrid, Spain |
34 | David Bagares Gata 3, 111 38 Stockholm |
35 | Female Founders House Bredgade 45B, 3., kontor, Copenhagen, 607 1260, Denmark |
36 | 12th Floor, Stockwerk, An der Welle 5, Frankfurt, 60322, Germany |
37 | Corso Giacomo Matteotti 3, Milan, 20121, Italy |
38 | 1 rue de la Paix, Paris, 75002, France |
Name of subsidiary | Country of incorporation | % of ownership interests and voting rights |
ICG US CLO 2014-1, Ltd. | Cayman Islands | 50% |
ICG US CLO 2014-2, Ltd. | Cayman Islands | 72% |
ICG US CLO 2014-3, Ltd. | Cayman Islands | 51% |
ICG US CLO 2015-1, Ltd. | Cayman Islands | 50% |
ICG US CLO 2015-2R, Ltd. | Cayman Islands | 83% |
ICG US CLO 2016-1, Ltd. | Cayman Islands | 63% |
ICG US CLO 2017-1, Ltd. | Cayman Islands | 60% |
ICG US CLO 2020-1, Ltd. | Cayman Islands | 52% |
ICG EURO CLO 2021-1 DAC | Ireland | 67% |
ICG EURO CLO 2023-2 DAC | Ireland | 100% |
St. Paul's CLO II DAC | Ireland | 85% |
St. Paul's CLO III-R DAC | Ireland | 62% |
St. Paul's CLO VI DAC | Ireland | 53% |
St. Paul's CLO VIII DAC | Ireland | 53% |
St. Paul's CLO XI DAC | Ireland | 57% |
ICG Euro CLO 2023-1 DAC | Ireland | 100% |
ICG Enterprise Carry (1)LP | Jersey | 100% |
ICG Enterprise Carry (2)LP | Jersey | 50% |
ICG US Senior Loan Fund | Cayman Islands | 100% |
ICG Total Credit (Global) SCA | Luxembourg | 100% |
ICG Newground RE Finance Trust 1 | Australia | 100% |
Company | Registered number | Member(s) |
ICG FMC Limited | 7266173 | Intermediate Capital Group plc |
ICG Global Investment UK Limited | 7647419 | Intermediate Capital Group plc |
ICG Japan (Funding 2)Limited | 9125779 | Intermediate Capital Group plc |
ICG Longbow Development (Brighton)Limited | 8802752 | Intermediate Capital Group plc |
ICG Longbow Richmond Limited | 11210259 | Intermediate Capital Group plc |
ICG Longbow BTR Limited | 11177993 | Intermediate Capital Group plc |
ICG Longbow Senior Debt I GP Limited | 2276839 | Intermediate Capital Group plc |
Intermediate Capital Investments Limited | 2327070 | Intermediate Capital Group plc |
LREC Partners Investments No. 2 Limited | 7428335 | Intermediate Capital Group plc |
ICG Longbow Development Debt Limited | 9907841 | ICG-Longbow Development GP LLP |
ICG IC Holdco Limited | 14542130 | Intermediate Capital Group plc |
ICG-Longbow Development GP LLP | OC396833 | Intermediate Capital Group plc, ICG FMC Limited |
ICG-Longbow Investment 3 LLP | OC395389 | ICG FMC Limited, Intermediate Capital Managers Limited |
ICG-Longbow Senior GP LLP | OC427634 | Intermediate Capital Group plc, ICG FMC Limited |
Proportion of | Proportion of | ||||||
ownership | Income | ownership | Income | ||||
interest/voting | distributions | interest/voting | distributions | ||||
rights held by the | received from | rights held by the | received from | ||||
Group | associate | Group | associate | ||||
Name of associate | Principal activity | Country of incorporation | 2024 | 2024 | 2023 | 2023 | |
ICG Europe Fund V Jersey Limited | Investment company | Jersey | 20% | 4.5 | 20% | 11.0 | |
ICG Europe Fund VI Jersey Limited | Investment company | Jersey | 17% | (3) | 17% | 24.7 | |
ICG North American Private Debt Fund | Investment company | United States of America | 20% | 1.1 | 20% | 5.5 | |
ICG Asia Pacific Fund III Singapore Pte. Limited | Investment company | Singapore | 20% | 4.1 | 20% | (1.2) | |
Ambient Enterprises LLC | Investment company | United States of America | 43% | – | 50% | – | |
KIK Equity Co-invest LLC | Investment company | United States of America | 25% | – | 25% | – | |
Seaway Topco, LP | Investment company | United States of America | 49% | – | –% | – |
Proportion of ownership | Proportion of voting | ||||
interest held by the Group | rights held by the Group | ||||
Name of joint venture | Accounting method | Principal activity | Country of incorporation | 2024 | 2024 |
Nomura ICG KK | Equity | Advisory company | Japan | –% | –% |
Brighton Marina Group Limited | Fair value | Investment company | United Kingdom | 70% | 70% |
ICG Fund VI Jersey Limited | ||
2024 | 2023 | |
£m | £m | |
Current assets | 0.6 | 8.1 |
Non-current assets | 975.4 | 1,023.9 |
Current liabilities | – | (55.8) |
976.0 | 976.2 | |
Revenue | 185.0 | 47. 3 |
Expenses | (0.2) | (24.1) |
Total comprehensive income | 184.8 | 23.2 |
2024 | ||||||
Investment in | Management fees | Performance fees | Maximum | |||
Fund | receivable | Management fee rates | receivable | Performance fee rates | exposure to loss | |
Funds | £m | £m | % | £m | % | £m |
CLOs | 295.9 | 4.2 | 0.19% to 0.50% | – | 0.05% to 0.20% | 300.1 |
Credit Funds | 22.1 | 9. 3 | 0.29% to 1.50% | 13.0 | 20% of returns in excess of 0% for Alternative Credit Fund only | 44.4 |
Corporate Investment Funds | 1,402.7 | 61.6 | 0.43% to 1.50% | 66.4 | 20%–25% of total performance fee of 10%–20% of profit over the threshold | 1,530.7 |
Real Asset Funds | 401.6 | 17.7 | 0.30% to 1.24% | – | 20% of total performance fee of 15%–20% of profit over the threshold | 419.3 |
Secondaries Funds | 455.8 | 38.5 | 0.75% to 1.37% | 4.3 | 20% of total performance fee of 12.5%–20% of profit over the threshold | 498.6 |
Total | 2,578.1 | 131.3 | 83.7 | 2,793.1 |
2023 | ||||||
Investment in | Management fees | Performance fees | Maximum | |||
Fund | receivable | Management fee rates | receivable | Performance fee rates | exposure to loss | |
Funds | £m | £m | % | £m | % | £m |
CLOs | 298.3 | 4.1 | 0.19% to 0.50% | – | 0.05% to 0.20% | 302.4 |
Credit Funds | 65.9 | 8.6 | 0.29% to 1.50% | (0.3) | 20% of returns in excess of 0% for Alternative Credit Fund only | 74.2 |
Corporate Investment Funds | 1,341.5 | 55.9 | 0.43% to 1.50% | 37.6 | 20%–25% of total performance fee of 20% of profit over the threshold | 1,435.0 |
Real Asset Funds | 288.5 | 12.0 | 0.30% to 1.24% | – | 20% of returns in excess of 9% IRR | 300.5 |
Secondaries Funds | 441.1 | 20.2 | 0.75% to 1.37% | 0.2 | 10%–20% of total performance fee of 8%–20% of profit over the threshold | 461.5 |
Total | 2,435.3 | 100.8 | 37. 5 | 2,573.6 |
Year ended | Year ended | ||
31 March 2024 | 31 March 2023 | ||
Group | Group | ||
Notes | £m | £m | |
Profit before tax from continuing operations | 530.8 | 251.0 | |
Adjustments for non-cash items: | |||
Fee and other operating income | 3 | (554.8) | (483.6) |
Net investment returns | 9 | (405.3) | (172.5) |
Interest income | 8 | (21.6) | (15.5) |
Net fair value (gain)/loss on derivatives | (22.8) | 34.9 | |
Impact of movement in foreign exchange rates | 33.3 | (17.8) | |
Interest expense | 10 | 49.5 | 64.6 |
Depreciation, amortisation and impairment of property, plant, equipment and intangible assets | 16, 17 | 18.0 | 18.2 |
Share-based payment expense | 43.9 | 39. 5 | |
Change in disposal groups held for sale | – | (8.8) | |
Working capital changes: | |||
Increase in trade and other receivables | (88.7) | (12.0) | |
Decrease in trade and other payables | (17.7) | (196.9) | |
(435.4) | (498.9) | ||
Proceeds from sale of current financial assets and disposal groups held for sale | 319.2 | 45.5 | |
Purchase of current financial assets and disposal groups held for sale | (312.1) | (211.9) | |
Purchase of investments | (1,729.7) | (1,374.6) | |
Proceeds from sales and maturities of investments | 2,233.1 | 1,721.8 | |
Issuance of CLO notes1 | – | 0.4 | |
Redemption of CLO notes1 | (389.1) | (45.6) | |
Interest received2 | 447.2 | 322.6 | |
Dividends received2 | 47.0 | 40.2 | |
Fee and other operating income received | 496.4 | 587.9 | |
Interest paid | (379.5) | (263.4) | |
Cash flows generated from operations | 297.1 | 324.0 | |
Taxes paid | (41.2) | (32.4) | |
Net cash flows from operating activities | 255.9 | 291.6 |
Year ended | Year ended | ||
31 March 2024 | 31 March 2023 | ||
Company | Company | ||
Notes | £m | £m | |
Profit before tax from continuing operations | 298.2 | 51.5 | |
Adjustments for non-cash items: | |||
Fee and other operating income | (16.3) | (3.9) | |
Dividend income | (240.0) | (386.6) | |
Interest income | (75.1) | (53.7) | |
Net investment returns | (8.9) | (0.7) | |
Net fair value (gain)/loss on derivatives | (23.5) | 7. 5 | |
Impact of movement in foreign exchange rates | (99.7) | 141.1 | |
Interest expense | 124.4 | 124.9 | |
Depreciation, amortisation and impairment of property, equipment and intangible assets | 16, 17 | 10.9 | 12.0 |
Write-down of intercompany loan balance | 12.2 | 12.7 | |
Share-based payment expense | 43.9 | 39. 5 | |
Intragroup reallocation of incurred costs | (80.6) | (152.0) | |
Working capital changes: | |||
Decrease in trade and other receivables | 7. 3 | 4.5 | |
Decrease in trade and other payables | (118.0) | (15.8) | |
(165.2) | (219.0) | ||
Proceeds from sale of current financial assets | – | 34.2 | |
Purchase of current financial assets | – | (134.6) | |
Purchase of investments | (28.0) | (73.1) | |
Proceeds from sales and maturities of investments | 70.1 | 127.5 | |
Interest received | 21.4 | 6.0 | |
Fee and other operating income received | 11.7 | 5.0 | |
Interest paid | (46.8) | (60.3) | |
Cash flows used in operations | (136.8) | (314.3) | |
Taxes paid | (24.2) | (20.8) | |
Net cash flows used in operating activities | (161.0) | (335.1) |